These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16729789)

  • 1. Use of nebulized inhaled corticosteroids among older adult patients: an assessment of outcomes.
    Marcus P; Oppenheimer EA; Patel PA; Katz LM; Doyle JJ
    Ann Allergy Asthma Immunol; 2006 May; 96(5):736-43. PubMed ID: 16729789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS; Yawn BP
    Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
    Delea TE; Hagiwara M; Stanford RH; Stempel DA
    Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of recurrent emergency department visits or hospitalizations in children with asthma receiving nebulized budesonide inhalation suspension compared with other asthma medications.
    McLaughlin T; Leibman C; Patel P; Camargo CA
    Curr Med Res Opin; 2007 Jun; 23(6):1319-28. PubMed ID: 17559731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled corticosteroid use and outcomes in pregnancy.
    Schatz M; Leibman C
    Ann Allergy Asthma Immunol; 2005 Sep; 95(3):234-8. PubMed ID: 16200813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
    Akazawa M; Biddle AK; Stearns SC
    Clin Ther; 2008; 30 Spec No():1003-16. PubMed ID: 18640475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled corticosteroids vs leukotriene receptor antagonists: health care costs across varying asthma severities.
    O'Connor RD; Parasuraman B; Roberts C; Leibman C
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):236-43. PubMed ID: 16937758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled corticosteroid use and associated outcomes in elderly patients with moderate to severe chronic pulmonary disease.
    Balkrishnan R; Christensen DB
    Clin Ther; 2000 Apr; 22(4):452-69. PubMed ID: 10823366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice.
    Goossens LM; Riemersma RA; Postma DS; van der Molen T; Rutten-van Mölken MP
    Adv Ther; 2009 Sep; 26(9):872-85. PubMed ID: 19768640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
    Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
    Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and costs of patients with persistent asthma treated with beclomethasone dipropionate hydrofluoroalkane or fluticasone propionate.
    Lage MJ; Gross GN; Brewster C; Spalitto A
    Adv Ther; 2009 Aug; 26(8):762-75. PubMed ID: 19669630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New measure of adherence adjusted for prescription patterns: the case of adults with asthma treated with inhaled corticosteroid monotherapy.
    Blais L; Kettani FZ; Beauchesne MF; Lemière C; Perreault S; Forget A
    Ann Pharmacother; 2011 Mar; 45(3):335-41. PubMed ID: 21386018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs and resource use of mild persistent asthma patients initiated on controller therapy.
    Colice GL; Yu AP; Ivanova JI; Hsieh M; Birnbaum HG; Lage MJ; Brewster C
    J Asthma; 2008 May; 45(4):293-9. PubMed ID: 18446593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone ultrasonometric features and growth hormone secretion in asthmatic patients during chronic inhaled corticosteroid therapy.
    Malerba M; Bossoni S; Radaeli A; Mori E; Romanelli G; Tantucci C; Giustina A; Grassi V
    Bone; 2006 Jan; 38(1):119-24. PubMed ID: 16154397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observational study of the effects of using montelukast vs fluticasone in patients matched at baseline.
    Allen-Ramey FC; Duong PT; Riedel AA; Markson LE; Weiss KB
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):373-80. PubMed ID: 15521374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asthma-related health care resource use among patients starting fluticasone or montelukast therapy.
    Allen-Ramey FC; Anstatt DT; Sajjan SG; Markson LE
    Pharmacotherapy; 2005 Dec; 25(12):1752-60. PubMed ID: 16305295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.